News | January 21, 2026
Senores Pharmaceuticals reports stellar Q3 FY26 growth; PAT surges 105%
In Q3 FY26, Senores posted consolidated revenue of Rs. 175 crore, up 64% year-on-year.
In Q3 FY26, Senores posted consolidated revenue of Rs. 175 crore, up 64% year-on-year.
Tatva Chintan Pharma Chem has reported total income of Rs. 133.06 crore during the period ended December 31, 2025
The company recorded revenue of Rs. 1,065 crore in the third quarter of FY26
Within India, Dabur expects its Home & Personal Care business to deliver double-digit growth,
The company’s consolidated revenue from operations rose to Rs. 361.13 crore in Q2 FY26 and Rs. 707.67 crore for the first half
Consolidated revenue from operations stood at Rs. 111.05 crore
Total income for the period stood at Rs. 7101.28 crore
Organic capex during the quarter amounted to Rs. 491.1 crore, supporting ongoing business expansion initiatives
Poly Medicure has reported total income of Rs. 477.82 crore during the period ended September 30, 2025
Syngene International has reported total income of Rs. 926 crore during the period ended September 30, 2025
Subscribe To Our Newsletter & Stay Updated
